Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „toripalimab“
Suchtreffer
Begriffe & Kennungen
Loqtorzi · 4.5 · No formal interaction studies have been performed. Since toripalimab is cleared from the circulation through c
Eintrag öffnenLoqtorzi · 4.5 · The use of systemic corticosteroids or immunosuppressants before starting toripalimab should be avoided becaus
Eintrag öffnenLoqtorzi · 4.8 · 13 In patients receiving toripalimab in JUPITER-02 and JUPITER-06, diabetes mellitus occurred in 0.2% (1/403)
Eintrag öffnenLoqtorzi · 4.8 · 14 discontinuation of toripalimab in 3 (0.2%) patients. Common symptoms of infusion-related reaction include f
Eintrag öffnenLoqtorzi · 4.8 · Elderly Of the 403 patients treated with toripalimab in combination with platinum-based chemotherapy in clinic
Eintrag öffnenLoqtorzi · 4.8 · Hypothyroidism occurred in 17.1% (69/403) of patients receiving toripalimab in JUPITER-02 and JUPITER-06, with
Eintrag öffnenLoqtorzi · 4.8 · Immune-related colitis Immune-related colitis occurred in 0.7% (3/403) of patients receiving toripalimab in JU
Eintrag öffnenLoqtorzi · 4.8 · Immune-related myositis Immune-related myositis occurred in 0.5% (2/403) of patients receiving toripalimab in
Eintrag öffnenLoqtorzi · 4.8 · Immune-related nephritis Immune-related nephritis occurred in 0.2% (1/403) of patients receiving toripalimab i
Eintrag öffnenLoqtorzi · 4.8 · Immune-related pneumonitis Immune-related pneumonitis occurred in 3.2% (13/403) patients receiving toripalimab
Eintrag öffnenLoqtorzi · 4.8 · In patients receiving toripalimab in JUPITER-02 and JUPITER-06, hyperthyroidism occurred in 2.0% (8/403) of pa
Eintrag öffnenLoqtorzi · 4.8 · In patients receiving toripalimab in JUPITER-02 and JUPITER-06, hypophysitis occurred in 0.2% (1/403) of patie
Eintrag öffnenLoqtorzi · 4.8 · Infusion related reactions Of the 403 patients who received toripalimab in combination with platinum containin
Eintrag öffnenLoqtorzi · 4.8 · Overall, infusion related reactions occurred in 28 (1.8%) of 1514 patients treated with toripalimab, including
Eintrag öffnenLoqtorzi · 4.8 · Table 2: Adverse reactions in patients treated with toripalimab
Eintrag öffnenLoqtorzi · 4.8 · Tabulated list of adverse reactions Adverse reactions observed in clinical studies of toripalimab as monothera
Eintrag öffnenLoqtorzi · 4.8 · The safety data is based on 1 514 patients exposed to toripalimab (of which 1 100 patients were exposed to tor
Eintrag öffnenLoqtorzi · 4.8 · Thyroiditis occurred in 2.0% (8/403) of patients receiving toripalimab in JUPITER-02 and JUPITER-06, including
Eintrag öffnenLoqtorzi · 4.8 · Toripalimab in combination with platinum containing chemotherapy (see section 4.2) The safety of toripalimab i
Eintrag öffnenLoqtorzi · 4.8 · When toripalimab is administered in combination with chemotherapy, refer to the SmPCs for the respective combi
Eintrag öffnen